From “AUA Daily Scope”: In JAMA Oncology is a study showing “men with low-risk prostate cancer — regardless of clinical characteristics or tumor biology — are being overtreated, often with radiation therapy.” Radiation was given in these men (who likely needed no treatment at all) 58% of the time. Radical Prostatectomy was used in 19%, and Active Surveillance in only 10% of the men.

However, in the same issue of “Daily Scope” was a report from Medscape showing men with Intermediate-risk prostate cancer treated with Active Surveillance may have a decrease in survival.

Take-home message: Men with low-risk tumors have the luxury of Active Surveillance and should not be pushed into treatment. Men with Intermediate-risk tumors are tempting fate by not getting treated promptly. All prostate cancers are not created equally.